Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens

Integrase strand transfer inhibitor (INSTI)-containing regimens in HIV-1-infected patients have experienced a global increase. Recently, WHO has emphasized the need to fast-track the transition to dolutegravir (DTG)-based antiretroviral (ARV) treatments. However, continued surveillance of INSTI resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil, Horacio, Delgado, Elena, Benito, Sonia, Moreno-Lorenzo, María, Thomson, Michael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792149/
https://www.ncbi.nlm.nih.gov/pubmed/36578581
http://dx.doi.org/10.3389/fmicb.2022.1051096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792149/
https://www.ncbi.nlm.nih.gov/pubmed/36578581
http://dx.doi.org/10.3389/fmicb.2022.1051096

Ejemplares similares